Strs Ohio Karuna Therapeutics, Inc. Transaction History

Strs Ohio

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Jul 31, 2023	SELL	$176.32 - $240.22 $502,335 - $684,386	-2,849 Reduced 50.88%	2,751 $596,000
Q1 2023 Aug 02, 2023	BUY	$161.33 - $204.36 $459,629 - $582,221	2,849 Added 103.56%	5,600 $1.02 Million
Q1 2023 Apr 27, 2023	SELL	$161.33 - $204.36 $322,660 - $408,720	-2,000 Reduced 26.32%	5,600 $1.02 Million
Q4 2022 Jan 26, 2023	SELL	$191.53 - $236.82 $287,295 - $355,230	-1,500 Reduced 16.48%	7,600 $1.49 Million
Q3 2022 Oct 27, 2022	BUY	$123.79 - $277.42 $557,055 - $1.25 Million	4,500 Added 97.83%	9,100 $2.05 Million
Q2 2022 Jul 25, 2022	BUY	$93.97 - $143.33 $28,191 - $42,999	300 Added 6.98%	4,600 $581,000
Q2 2021 Jul 26, 2021	BUY	$107.45 - $135.95 $42,980 - $54,379	400 Added 10.26%	4,300 $490,000
Q1 2021 Apr 23, 2021	SELL	$95.46 - $133.08 $9,546 - $13,308	-100 Reduced 2.5%	3,900 $468,000
Q2 2020 Jul 23, 2020	BUY	$62.14 - $117.21 $80,782 - $152,373	1,300 Added 48.15%	4,000 $445,000
Q1 2020 Apr 23, 2020	BUY	$60.41 - $115.92 $90,615 - $173,880	1,500 Added 125.0%	2,700 $194,000
Q3 2019 Oct 21, 2019	BUY	$16.05 - $27.35 $19,260 - $32,820	1,200 New	1,200 $19,000

332K

Ticker KRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 33,965,000
Description
Karuna Therapeutics, Inc., a clinical-stage biopharmaceutical company, creates and delivers transformative medicines for people living with psychiatric and neurological conditions. Its lead product candidate is KarXT, an oral modulator of muscarinic receptors that is in Phase III clinical trial for the treatment of acute psychosis in patients wi...

Get notified when there are updates to the investment portfolio of Strs Ohio, based on Form 13F filings with the SEC.

Stay updated on Strs Ohio with notifications on news.